Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000534408 | SCV000652741 | uncertain significance | Congenital myopathy with internal nuclei and atypical cores | 2023-01-17 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 122 of the CCDC78 protein (p.Pro122Leu). This variant is present in population databases (rs745392382, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with CCDC78-related conditions. ClinVar contains an entry for this variant (Variation ID: 473257). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CCDC78 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001755887 | SCV002007083 | likely benign | not provided | 2021-02-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004601206 | SCV005099154 | uncertain significance | Inborn genetic diseases | 2024-05-31 | criteria provided, single submitter | clinical testing | The c.365C>T (p.P122L) alteration is located in exon 4 (coding exon 4) of the CCDC78 gene. This alteration results from a C to T substitution at nucleotide position 365, causing the proline (P) at amino acid position 122 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |